FXVIEW Goes Global, Sets up a Subsidiary in Saint Vincent and Grenadines
Fxview, Cyprus based forex and CFDs financial services company, announced today that it has set up an offshore subsidiary in St Vincent & The Grenadines. Until now, Fxview has been operating with its EU licenses from Cyprus.
Charlgate SVG LLC, their locally incorporated arm will ensure the expansion of products and services on Fxview’s platforms. It will also allow them to offer regulated forex and CFDs trading services to traders around the globe.
Fxview operates in Europe with its multiple European Licenses and is already an established brand in the EU market. Earlier this month, the company was acquired by a global FinTech leader Finvasia Group.
“We anticipate that many more traders will join our platform where we plan to offer additional products and services like research & analysis, higher leverage, sophisticated trading tools, social trading, MAM / PAMM services, affiliate programs, loyalty reward programs and more,” said Rahul Bansal, Director of Charlgate SVG LLC.
“We have been successfully operating uninterrupted in the trading industry for more than a decade, and one of our missions has always been to grow our regulatory framework,” said Sarvjeet Virk, Managing Director of FINVASIA Group.
“The offshore entity is a key milestone for Fxivew. This will allow our existing and new clients to take full advantage of our innovative ecosystem ranging from state-of-the-art platforms & tools, lightning-fast execution, excellent trading conditions and stellar customer support” he further added.
About Fxview
Fxview is a brand owned and operated by Charlgate Ltd (a Finvasia Group Company) with its headquarters in Limassol Cyprus. Charlgate Ltd operates under the European Markets in Financial Instruments Directive (MiFid) and is regulated by CySec under license 367/18 since 2018 and is a Member of the Investor Compensation Fund (ICF).
Charlgate Ltd is also registered with the UK Financial Conduct Authority – FCA ( 850138), the German Federal Financial Supervisory Authority – BaFin ( 157125), the French Autorité de Contrôle Prudentiel et de Résolution – ACPR ( 85051), the Italian Commissione Nazionale per le Società e la Borsa – CONSOB ( 5151), the Spanish Comisión Nacional de Mercado de Valores – CNVM ( 4892), the Norway Finanstilsynet – ( FT00118545).
Know more: https://fxview.com/
About FINVASIA Group
FINVASIA is a multi-disciplinary, multinational organisation that invests in technology-oriented business and products. It is registered with a gamut of regulatory bodies across the world in various capacities. Finvasia (along with its subsidiaries and sister concerns) is registered with SEC, USA (152771 ), Reserve Bank of India as an NBFC, National Stock Exchange of India as Professional Clearing member(M51912), Bombay Stock Exchange(4043), Multi Commodity Exchange of India(55135) and NCDEX as Trading Member(01259), Association of Mutual Funds of India(103331) and CDSL as Depository Participant(12084300).
Know more: https://finvasia.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210621005285/en/
Contact information
Media:
Ms. Sandeep Samra
        media@fxview.com 
         
        +35725251100
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corpay and National Hockey League Announce Multiyear North American Partnership4.11.2025 15:30:00 EET | Press release
Corpay, Inc.* (NYSE: CPAY), a global leader in corporate payments and the National Hockey League (NHL®) today announced a multiyear North American partnership, naming Corpay’s Cross-Border business the Official Foreign Exchange (FX) Provider of the NHL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251104740136/en/ Through this partnership, the NHL will be able to use Corpay Cross-Border’s innovative solutions to help mitigate foreign exchange exposure in their daily operations. The NHL will also benefit from Corpay’s award-winning platform, which allows for seamless global payment management from a single point of access. As part of the partnership, Corpay will have brand presence on the NHL’s digitally enhanced dasherboards and with in-stadium signage at NHL Winter Classic®, NHL Stadium Series™, and NHL Heritage Classic™, in addition to other activation opportunities at NHL tentpole events in future seasons. Corpay and th
Esri Supports IUCN Global Initiative for Nature-Based Education4.11.2025 15:00:00 EET | Press release
At the 2025 IUCN World Conservation Congress, Esri, the global leader in geographic information system (GIS) technology, announced a joint initiative with the International Union for Conservation of Nature (IUCN) and its Commission on Education and Communication to expand access to data, maps, and GIS technology in support of Nature-based Education (NbE) worldwide. Esri is making a $10 million in-kind donation to enable the development of a new NbE geoportal that will allow students, teachers, and IUCN conservationists around the world to understand and explore our planet through maps and the science of geography, collaborate on critical conservation solutions, and develop critical technical skills for future careers in conservation. This new initiative, now in the pilot phase of consultation and design, will support IUCN’s NbE aspirations to promote environmental learning and action as adopted by the Members during the IUCN World Conservation Congress in Abu Dhabi this October. This c
Visa and Transcard Collaborate to Deliver Advanced Embedded Working Capital Solutions in Freight & Logistics4.11.2025 15:00:00 EET | Press release
Visa and Transcard today announced the launch of a next-generation embedded finance platform, designed to power payments and working capital solutions in the freight and logistics industry. As a part of their joint effort, Visa and Transcard are also collaborating on agentic initiatives for the B2B segment. This alliance puts embedded credit and working capital solutions in the hands of freight forwarders and airline carriers on WebCargo by Freightos (Nasdaq: CRGO), a leading digital booking and payments platform in the freight industry. By combining Visa’s global expertise in commercial solutions with Transcard’s leading-edge payment orchestration technology, WebCargo users can now gain access to flexible credit terms, seamless onboarding and automated reconciliation for air cargo transactions. The solution, built on Visa’s virtual card infrastructure, unlocks the cash flow bottlenecks between freight forwarders and airlines, and elevates the digital freight booking and payment experi
Agendia to Present Five Posters Demonstrating the Expanding Clinical Utility of MammaPrint + BluePrint at the 2025 San Antonio Breast Cancer Symposium4.11.2025 14:00:00 EET | Press release
Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new results from the ongoing real-world FLEX Study (NCT03053193) at the 2025 San Antonio Breast Cancer Symposium (SABCS), taking place December 9-12 in San Antonio, Texas. The company will present five posters, led by Agendia investigators and independent academic collaborators, that collectively highlight the broad clinical impact of MammaPrint® + BluePrint® genomic profiling in optimizing treatment decisions and improving outcomes for patients with hormone receptor positive, HER2-negative (HR+/HER2–) early breast cancer (EBC). “We look forward to sharing these new findings from the FLEX Study, which spans more than 20,000 participants across 100 global sites, making it the largest and most diverse real-world evidence cohort for early-stage breast cancer,” said William Audeh, M.D., Chief Medical Officer at Agendia. “These results underscore our commitment to generating robust clinical evi
Nature Communications Study Supports HER2DX as a Genomic Tool for Tailored Therapy in Older Individuals With HER2+ Breast Cancer4.11.2025 14:00:00 EET | Press release
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company seeking to revolutionize precision oncology through biomarker innovation, today announced the publication of the study “HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy” in Nature Communications. This landmark study evaluated the HER2DX genomic assay in 154 individuals aged 70–80 years enrolled in the RESPECT trial (NCT01104935), a randomized phase III study comparing adjuvant trastuzumab with or without chemotherapy. The analysis, known as Trans-RESPECT, is the first to evaluate HER2DX in an older adult population, a demographic historically underrepresented in clinical trials. Bringing Precision Oncology to Older Individuals with HER2+ Disease Despite the growing number of older adults diagnosed with HER2-positive early breast cancer, optimal treatment strategies remain unclear. Many face increased risks of chemotherapy-related toxicit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
